Literature DB >> 2755874

Effects of guinea pig vasoactive intestinal peptide on the isolated perfused guinea pig heart.

D B Hoover1.   

Abstract

The pharmacological effects of guinea pig vasoactive intestinal peptide (VIP) were studied in isolated perfused guinea pig hearts. Bolus injections of VIP produced a dose-dependent tachycardia that was not affected by atenolol. A decrease in amplitude of ventricular contractions occurred in response to all doses of VIP. This response was preceded by a small increase in amplitude in 3 of 6 hearts at the highest dose. VIP produced a decrease in perfusion pressure which was prominent after coronary tone was elevated with [Arg8]-vasopressin. The present findings support speculation that VIP may have a role in the regulation of heart rate and coronary blood flow.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2755874     DOI: 10.1016/0196-9781(89)90041-7

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  4 in total

1.  Differential activation of guinea pig intrinsic cardiac neurons by the PAC1 agonists maxadilan and pituitary adenylate cyclase-activating polypeptide 27 (PACAP27).

Authors:  Donald B Hoover; John D Tompkins; Rodney L Parsons
Journal:  J Pharmacol Exp Ther       Date:  2009-07-14       Impact factor: 4.030

2.  Vasoactive intestinal polypeptide modulation of nicotinic ACh receptor channels in rat intracardiac neurones.

Authors:  J Cuevas; D J Adams
Journal:  J Physiol       Date:  1996-06-01       Impact factor: 5.182

3.  PAC₁ receptors mediate positive chronotropic responses to PACAP-27 and VIP in isolated mouse atria.

Authors:  Donald B Hoover; Beatrice M Girard; Jeffrey L Hoover; Rodney L Parsons
Journal:  Eur J Pharmacol       Date:  2013-05-09       Impact factor: 4.432

Review 4.  Neurohumoral Control of Sinoatrial Node Activity and Heart Rate: Insight From Experimental Models and Findings From Humans.

Authors:  Eilidh A MacDonald; Robert A Rose; T Alexander Quinn
Journal:  Front Physiol       Date:  2020-03-03       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.